Respiratory Disturbance Index Test

Your breathing during sleep tells a story your waking life cannot. The respiratory disturbance index, or RDI, is a number generated during a sleep study that counts how many times per hour your airway caused a disruption, whether a full stop in breathing, a partial collapse, or a brief struggle that jolted your brain toward waking. It captures more than the more commonly reported index of apneas and hypopneas (called the apnea-hypopnea index, or AHI) because it also counts a third type of event: moments where your airway resists airflow enough to trigger a brief arousal without fully qualifying as a breathing pause. Knowing your RDI gives you a more complete picture of how hard your body is working overnight.

What RDI Measures and Why It Differs from AHI

Sleep medicine uses several overlapping metrics to describe nighttime breathing problems, and the distinctions between them are clinically meaningful. The AHI counts complete breathing stoppages (apneas) plus partial blockages (hypopneas) per hour of sleep. The RDI adds a third category: brief periods where your airway narrows and your breathing effort increases enough to partially wake your brain, called respiratory effort-related arousals, or RERAs. These events do not cause enough oxygen drop to qualify as hypopneas, but they still fragment sleep and stress the cardiovascular system. The formal formula is: RDI equals the number of apneas plus hypopneas plus RERAs, multiplied by 60, divided by total sleep time in minutes.

Because RDI includes everything AHI does plus RERAs on top, your RDI will always be equal to or greater than your AHI. How much greater depends on which scoring rules your sleep lab uses. Under older rules that required a 4% oxygen drop to count a hypopnea, RERAs accounted for approximately 27.7% of the total RDI in people with sleep apnea. Under current rules that accept a 3% drop, RERAs contribute only about 4.3% to the RDI, because many events previously labeled as RERAs are now captured as hypopneas. The practical gap between AHI and RDI has narrowed considerably under modern scoring.

Severity Ranges and What Your Score Means

The American Academy of Sleep Medicine uses the same thresholds for RDI that it uses for AHI. If your RDI is below 5, your nighttime breathing is considered normal. If your score falls between 5 and 15, it means your airway is causing mild disruptions roughly every 4 to 12 minutes of sleep. Between 15 and 30 is moderate, meaning your airway is disrupting sleep roughly every 2 to 4 minutes. At 30 or above, the classification is severe, meaning your airway is compromising sleep at least once every 2 minutes.

Both the American Academy of Sleep Medicine and Medicare define a diagnosis of obstructive sleep apnea as an AHI or RDI of 15 or more events per hour, or 5 or more per hour if you also have documented symptoms such as excessive daytime sleepiness, impaired thinking, mood changes, insomnia, or a history of high blood pressure, coronary artery disease, or stroke.

Who Is Most Likely to Have an Elevated RDI

Understanding your personal risk helps you decide whether to seek testing and how aggressively to act on your result. Several biological and anatomical factors drive RDI upward, and knowing them lets you contextualize your score.

Body weight is the single most modifiable driver. A 10% increase in body weight is associated with a 32% increase in AHI and a 6-fold increase in the risk of developing sleep apnea over a 4-year period. Among people referred for sleep studies, 60 to 90% carry excess weight, and obese individuals face a relative risk of 10 or greater for developing sleep apnea. Central body fat, particularly around the neck, predicts severity independently of overall body mass index. A neck circumference above 17 inches in men or above 16 inches in women independently predicts sleep apnea severity.

Sex shapes your baseline risk substantially. Sleep apnea is 2 to 4 times more prevalent in men than in women, with an odds ratio of 3.1 (meaning men are about 3 times as likely to have it, after accounting for other factors). However, this gap narrows significantly with age and closes near age 50. After menopause, women face a 2.6 to 3.5-fold higher risk compared to premenopausal women, likely because the hormone progesterone helps maintain upper airway muscle tone and breathing drive during sleep. Women also tend to have shorter breathing events, more partial blockages rather than full stoppages, and less oxygen drop per event, which can make sleep apnea harder to detect.

Age increases risk progressively through the 60s and 70s, then levels off. For women, the odds of a meaningfully elevated AHI rise by approximately 140% per decade of life (odds ratio 2.41), while in men the increase is only about 15% per decade (odds ratio 1.15). After age 60, the influence of body weight on AHI weakens, and structural factors in the airway and changes in muscle tone become relatively more important.

Facial and jaw structure also matter independent of weight. A recessed jaw, narrow upper palate, or small airway opening increases risk regardless of body size, and this is particularly relevant in people of East Asian ancestry, where sleep apnea can be severe even with modest weight gain. Several medical conditions are associated with high rates of elevated RDI: hypothyroidism and acromegaly, which cause soft tissue changes in the airway; polycystic ovarian syndrome, where higher androgen levels may increase tongue muscle mass; heart failure, where 40 to 60% of those affected have sleep apnea; and atrial fibrillation, which has a strong bidirectional relationship with sleep-disordered breathing.

Race and ethnicity influence prevalence as well. In the Multi-Ethnic Study of Atherosclerosis, moderate-to-severe sleep apnea was present in 30.3% of White participants, 38.2% of Hispanic participants, and 39.4% of participants of Chinese descent. Black, Hispanic, and Native American individuals have higher overall prevalence compared to White individuals, with differences partly attributable to higher rates of obesity, asthma, and tobacco use alongside structural social factors.

What Moves This Biomarker

RDI is not fixed. The single most impactful thing you can do to lower it is reduce body weight if you carry excess. A 10% weight gain is associated with a 32% increase in AHI, which implies that meaningful weight loss works in the opposite direction with similar magnitude. The relationship between central adiposity and airway collapse means that fat reduction around the neck and abdomen is particularly relevant, beyond overall body weight.

Questions This Biomarker Can Answer

• Am I experiencing enough nighttime breathing disruptions to explain my daytime fatigue, poor concentration, or mood changes?
• Does my airway cause sleep fragmentation through arousal-triggering events that a standard home sleep test would miss?
• Is my level of breathing disruption severe enough to qualify for treatment under clinical guidelines?
• How does my RDI compare to the threshold associated with cardiovascular and metabolic risk, and where does my score place me on that spectrum?
• Has my RDI changed after an intervention such as weight loss, positional therapy, or a medical device, and is my airway responding?